Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
14,731
archived clinical trials in
Psychiatric

Genomics Used to Improve DEpression Decisions
A 12-Week, Randomized, Double-Blind, Controlled Evaluation Followed by an Open-Label 12-Week Follow-up Period of the Impact of GeneSight Psychotropic on Response to Psychotropic Treatment in Outpatients Suffering From a Major Depressive Disorder (MDD) and Having Had - Within the Current Episode - an Inadequate Response to at Least One Psychotropic Medication Included in GeneSight Psychotropic
Status: Enrolling
Updated:  12/31/1969
University of Texas Southwestern Medical Center
mi
from
Dallas, TX
Genomics Used to Improve DEpression Decisions
A 12-Week, Randomized, Double-Blind, Controlled Evaluation Followed by an Open-Label 12-Week Follow-up Period of the Impact of GeneSight Psychotropic on Response to Psychotropic Treatment in Outpatients Suffering From a Major Depressive Disorder (MDD) and Having Had - Within the Current Episode - an Inadequate Response to at Least One Psychotropic Medication Included in GeneSight Psychotropic
Status: Enrolling
Updated: 12/31/1969
University of Texas Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Genomics Used to Improve DEpression Decisions
A 12-Week, Randomized, Double-Blind, Controlled Evaluation Followed by an Open-Label 12-Week Follow-up Period of the Impact of GeneSight Psychotropic on Response to Psychotropic Treatment in Outpatients Suffering From a Major Depressive Disorder (MDD) and Having Had - Within the Current Episode - an Inadequate Response to at Least One Psychotropic Medication Included in GeneSight Psychotropic
Status: Enrolling
Updated:  12/31/1969
Baylor College of Medicine
mi
from
Houston, TX
Genomics Used to Improve DEpression Decisions
A 12-Week, Randomized, Double-Blind, Controlled Evaluation Followed by an Open-Label 12-Week Follow-up Period of the Impact of GeneSight Psychotropic on Response to Psychotropic Treatment in Outpatients Suffering From a Major Depressive Disorder (MDD) and Having Had - Within the Current Episode - an Inadequate Response to at Least One Psychotropic Medication Included in GeneSight Psychotropic
Status: Enrolling
Updated: 12/31/1969
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
Genomics Used to Improve DEpression Decisions
A 12-Week, Randomized, Double-Blind, Controlled Evaluation Followed by an Open-Label 12-Week Follow-up Period of the Impact of GeneSight Psychotropic on Response to Psychotropic Treatment in Outpatients Suffering From a Major Depressive Disorder (MDD) and Having Had - Within the Current Episode - an Inadequate Response to at Least One Psychotropic Medication Included in GeneSight Psychotropic
Status: Enrolling
Updated:  12/31/1969
Alliance Research Group
mi
from
Richmond, VA
Genomics Used to Improve DEpression Decisions
A 12-Week, Randomized, Double-Blind, Controlled Evaluation Followed by an Open-Label 12-Week Follow-up Period of the Impact of GeneSight Psychotropic on Response to Psychotropic Treatment in Outpatients Suffering From a Major Depressive Disorder (MDD) and Having Had - Within the Current Episode - an Inadequate Response to at Least One Psychotropic Medication Included in GeneSight Psychotropic
Status: Enrolling
Updated: 12/31/1969
Alliance Research Group
mi
from
Richmond, VA
Click here to add this to my saved trials
Genomics Used to Improve DEpression Decisions
A 12-Week, Randomized, Double-Blind, Controlled Evaluation Followed by an Open-Label 12-Week Follow-up Period of the Impact of GeneSight Psychotropic on Response to Psychotropic Treatment in Outpatients Suffering From a Major Depressive Disorder (MDD) and Having Had - Within the Current Episode - an Inadequate Response to at Least One Psychotropic Medication Included in GeneSight Psychotropic
Status: Enrolling
Updated:  12/31/1969
Northwest Clinical Research Center
mi
from
Bellevue, WA
Genomics Used to Improve DEpression Decisions
A 12-Week, Randomized, Double-Blind, Controlled Evaluation Followed by an Open-Label 12-Week Follow-up Period of the Impact of GeneSight Psychotropic on Response to Psychotropic Treatment in Outpatients Suffering From a Major Depressive Disorder (MDD) and Having Had - Within the Current Episode - an Inadequate Response to at Least One Psychotropic Medication Included in GeneSight Psychotropic
Status: Enrolling
Updated: 12/31/1969
Northwest Clinical Research Center
mi
from
Bellevue, WA
Click here to add this to my saved trials
Genomics Used to Improve DEpression Decisions
A 12-Week, Randomized, Double-Blind, Controlled Evaluation Followed by an Open-Label 12-Week Follow-up Period of the Impact of GeneSight Psychotropic on Response to Psychotropic Treatment in Outpatients Suffering From a Major Depressive Disorder (MDD) and Having Had - Within the Current Episode - an Inadequate Response to at Least One Psychotropic Medication Included in GeneSight Psychotropic
Status: Enrolling
Updated:  12/31/1969
Summit Research Network LLC
mi
from
Seattle, WA
Genomics Used to Improve DEpression Decisions
A 12-Week, Randomized, Double-Blind, Controlled Evaluation Followed by an Open-Label 12-Week Follow-up Period of the Impact of GeneSight Psychotropic on Response to Psychotropic Treatment in Outpatients Suffering From a Major Depressive Disorder (MDD) and Having Had - Within the Current Episode - an Inadequate Response to at Least One Psychotropic Medication Included in GeneSight Psychotropic
Status: Enrolling
Updated: 12/31/1969
Summit Research Network LLC
mi
from
Seattle, WA
Click here to add this to my saved trials
Genomics Used to Improve DEpression Decisions
A 12-Week, Randomized, Double-Blind, Controlled Evaluation Followed by an Open-Label 12-Week Follow-up Period of the Impact of GeneSight Psychotropic on Response to Psychotropic Treatment in Outpatients Suffering From a Major Depressive Disorder (MDD) and Having Had - Within the Current Episode - an Inadequate Response to at Least One Psychotropic Medication Included in GeneSight Psychotropic
Status: Enrolling
Updated:  12/31/1969
Frontier Institute
mi
from
Spokane, WA
Genomics Used to Improve DEpression Decisions
A 12-Week, Randomized, Double-Blind, Controlled Evaluation Followed by an Open-Label 12-Week Follow-up Period of the Impact of GeneSight Psychotropic on Response to Psychotropic Treatment in Outpatients Suffering From a Major Depressive Disorder (MDD) and Having Had - Within the Current Episode - an Inadequate Response to at Least One Psychotropic Medication Included in GeneSight Psychotropic
Status: Enrolling
Updated: 12/31/1969
Frontier Institute
mi
from
Spokane, WA
Click here to add this to my saved trials
Genomics Used to Improve DEpression Decisions
A 12-Week, Randomized, Double-Blind, Controlled Evaluation Followed by an Open-Label 12-Week Follow-up Period of the Impact of GeneSight Psychotropic on Response to Psychotropic Treatment in Outpatients Suffering From a Major Depressive Disorder (MDD) and Having Had - Within the Current Episode - an Inadequate Response to at Least One Psychotropic Medication Included in GeneSight Psychotropic
Status: Enrolling
Updated:  12/31/1969
CITrials, Inc.
mi
from
Bellflower, CA
Genomics Used to Improve DEpression Decisions
A 12-Week, Randomized, Double-Blind, Controlled Evaluation Followed by an Open-Label 12-Week Follow-up Period of the Impact of GeneSight Psychotropic on Response to Psychotropic Treatment in Outpatients Suffering From a Major Depressive Disorder (MDD) and Having Had - Within the Current Episode - an Inadequate Response to at Least One Psychotropic Medication Included in GeneSight Psychotropic
Status: Enrolling
Updated: 12/31/1969
CITrials, Inc.
mi
from
Bellflower, CA
Click here to add this to my saved trials
Genomics Used to Improve DEpression Decisions
A 12-Week, Randomized, Double-Blind, Controlled Evaluation Followed by an Open-Label 12-Week Follow-up Period of the Impact of GeneSight Psychotropic on Response to Psychotropic Treatment in Outpatients Suffering From a Major Depressive Disorder (MDD) and Having Had - Within the Current Episode - an Inadequate Response to at Least One Psychotropic Medication Included in GeneSight Psychotropic
Status: Enrolling
Updated:  12/31/1969
CiTrials
mi
from
Costa Mesa, CA
Genomics Used to Improve DEpression Decisions
A 12-Week, Randomized, Double-Blind, Controlled Evaluation Followed by an Open-Label 12-Week Follow-up Period of the Impact of GeneSight Psychotropic on Response to Psychotropic Treatment in Outpatients Suffering From a Major Depressive Disorder (MDD) and Having Had - Within the Current Episode - an Inadequate Response to at Least One Psychotropic Medication Included in GeneSight Psychotropic
Status: Enrolling
Updated: 12/31/1969
CiTrials
mi
from
Costa Mesa, CA
Click here to add this to my saved trials
Genomics Used to Improve DEpression Decisions
A 12-Week, Randomized, Double-Blind, Controlled Evaluation Followed by an Open-Label 12-Week Follow-up Period of the Impact of GeneSight Psychotropic on Response to Psychotropic Treatment in Outpatients Suffering From a Major Depressive Disorder (MDD) and Having Had - Within the Current Episode - an Inadequate Response to at Least One Psychotropic Medication Included in GeneSight Psychotropic
Status: Enrolling
Updated:  12/31/1969
Mood and Anxiety Program at Emory University
mi
from
Atlanta, GA
Genomics Used to Improve DEpression Decisions
A 12-Week, Randomized, Double-Blind, Controlled Evaluation Followed by an Open-Label 12-Week Follow-up Period of the Impact of GeneSight Psychotropic on Response to Psychotropic Treatment in Outpatients Suffering From a Major Depressive Disorder (MDD) and Having Had - Within the Current Episode - an Inadequate Response to at Least One Psychotropic Medication Included in GeneSight Psychotropic
Status: Enrolling
Updated: 12/31/1969
Mood and Anxiety Program at Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
Genomics Used to Improve DEpression Decisions
A 12-Week, Randomized, Double-Blind, Controlled Evaluation Followed by an Open-Label 12-Week Follow-up Period of the Impact of GeneSight Psychotropic on Response to Psychotropic Treatment in Outpatients Suffering From a Major Depressive Disorder (MDD) and Having Had - Within the Current Episode - an Inadequate Response to at Least One Psychotropic Medication Included in GeneSight Psychotropic
Status: Enrolling
Updated:  12/31/1969
Washington University School of Medicine
mi
from
Saint Louis, MO
Genomics Used to Improve DEpression Decisions
A 12-Week, Randomized, Double-Blind, Controlled Evaluation Followed by an Open-Label 12-Week Follow-up Period of the Impact of GeneSight Psychotropic on Response to Psychotropic Treatment in Outpatients Suffering From a Major Depressive Disorder (MDD) and Having Had - Within the Current Episode - an Inadequate Response to at Least One Psychotropic Medication Included in GeneSight Psychotropic
Status: Enrolling
Updated: 12/31/1969
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Genomics Used to Improve DEpression Decisions
A 12-Week, Randomized, Double-Blind, Controlled Evaluation Followed by an Open-Label 12-Week Follow-up Period of the Impact of GeneSight Psychotropic on Response to Psychotropic Treatment in Outpatients Suffering From a Major Depressive Disorder (MDD) and Having Had - Within the Current Episode - an Inadequate Response to at Least One Psychotropic Medication Included in GeneSight Psychotropic
Status: Enrolling
Updated:  12/31/1969
PsychCare Consultants Research
mi
from
Saint Louis, MO
Genomics Used to Improve DEpression Decisions
A 12-Week, Randomized, Double-Blind, Controlled Evaluation Followed by an Open-Label 12-Week Follow-up Period of the Impact of GeneSight Psychotropic on Response to Psychotropic Treatment in Outpatients Suffering From a Major Depressive Disorder (MDD) and Having Had - Within the Current Episode - an Inadequate Response to at Least One Psychotropic Medication Included in GeneSight Psychotropic
Status: Enrolling
Updated: 12/31/1969
PsychCare Consultants Research
mi
from
Saint Louis, MO
Click here to add this to my saved trials
The ProGirls Study
Preventing HIV/STI Risk Behavior in Girls With Delinquency, Drug Abuse, & Trauma
Status: Enrolling
Updated:  12/31/1969
Oregon Research Institute
mi
from
Eugene, OR
The ProGirls Study
Preventing HIV/STI Risk Behavior in Girls With Delinquency, Drug Abuse, & Trauma
Status: Enrolling
Updated: 12/31/1969
Oregon Research Institute
mi
from
Eugene, OR
Click here to add this to my saved trials
Dissemination of Comprehensive Behavioral Intervention for Tics (CBIT) to Occupational Therapists: A Feasibility Study
Dissemination of Comprehensive Behavioral Intervention for Tics (CBIT) to Occupational Therapists: A Feasibility Study
Status: Enrolling
Updated:  12/31/1969
Weill-Cornell Medical College
mi
from
New York, NY
Dissemination of Comprehensive Behavioral Intervention for Tics (CBIT) to Occupational Therapists: A Feasibility Study
Dissemination of Comprehensive Behavioral Intervention for Tics (CBIT) to Occupational Therapists: A Feasibility Study
Status: Enrolling
Updated: 12/31/1969
Weill-Cornell Medical College
mi
from
New York, NY
Click here to add this to my saved trials
Neural Substrates of Approach-Avoidance Conflict
Neural Substrate of Approach-Avoidance Conflict
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Neural Substrates of Approach-Avoidance Conflict
Neural Substrate of Approach-Avoidance Conflict
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Decreasing the Incidence of Delirium After Cardiac Surgery
Decreasing the Incidence of Delirium After Cardiac Surgery
Status: Enrolling
Updated:  12/31/1969
Ronald Reagan UCLA Medical Center, Department of Anesthesiology
mi
from
Los Angeles, CA
Decreasing the Incidence of Delirium After Cardiac Surgery
Decreasing the Incidence of Delirium After Cardiac Surgery
Status: Enrolling
Updated: 12/31/1969
Ronald Reagan UCLA Medical Center, Department of Anesthesiology
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Child and Family Outcomes and Consumer Satisfaction for Online vs Staff-Delivered Parenting Intervention
Online vs Staff Delivery: Child & Family Outcomes, Value Analysis, Satisfaction
Status: Enrolling
Updated:  12/31/1969
Oregon Research Institute
mi
from
Eugene, OR
Child and Family Outcomes and Consumer Satisfaction for Online vs Staff-Delivered Parenting Intervention
Online vs Staff Delivery: Child & Family Outcomes, Value Analysis, Satisfaction
Status: Enrolling
Updated: 12/31/1969
Oregon Research Institute
mi
from
Eugene, OR
Click here to add this to my saved trials
Child and Family Outcomes and Consumer Satisfaction for Online vs Staff-Delivered Parenting Intervention
Online vs Staff Delivery: Child & Family Outcomes, Value Analysis, Satisfaction
Status: Enrolling
Updated:  12/31/1969
Parenting & Family Research Center, University of South Carolina
mi
from
Columbia, SC
Child and Family Outcomes and Consumer Satisfaction for Online vs Staff-Delivered Parenting Intervention
Online vs Staff Delivery: Child & Family Outcomes, Value Analysis, Satisfaction
Status: Enrolling
Updated: 12/31/1969
Parenting & Family Research Center, University of South Carolina
mi
from
Columbia, SC
Click here to add this to my saved trials
The Neurophysiological Effects of Intravenous Alcohol as Potential Biomarkers of Ketamine's Rapid Antidepressant Effects in Major Depressive Disorder
The Neurophysiological Effects of Intravenous Alcohol as Potential Biomarkers of Ketamine's Rapid Antidepressant Effects in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
The Neurophysiological Effects of Intravenous Alcohol as Potential Biomarkers of Ketamine's Rapid Antidepressant Effects in Major Depressive Disorder
The Neurophysiological Effects of Intravenous Alcohol as Potential Biomarkers of Ketamine's Rapid Antidepressant Effects in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Minocycline Augmentation to Clozapine
A Pilot Study of Minocycline Augmentation to Clozapine in Individuals With Treatment Resistant Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Grady Memorial Hospital
mi
from
Atlanta, GA
Minocycline Augmentation to Clozapine
A Pilot Study of Minocycline Augmentation to Clozapine in Individuals With Treatment Resistant Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Grady Memorial Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
Intervention Trial to Decrease Cardiovascular Risk in Persons With Serious Mental Illness
Comprehensive Cardiovascular Diseases (CVD) Risk Reduction Trial in Persons With Serious Mental Illness
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins ProHealth Clinical Research Facility
mi
from
Woodlawn, MD
Intervention Trial to Decrease Cardiovascular Risk in Persons With Serious Mental Illness
Comprehensive Cardiovascular Diseases (CVD) Risk Reduction Trial in Persons With Serious Mental Illness
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins ProHealth Clinical Research Facility
mi
from
Woodlawn, MD
Click here to add this to my saved trials
Testing a Promising Treatment for Youth Substance Abuse in a Community Setting
Testing a Promising Treatment for Youth Substance Abuse in a Community Setting
Status: Enrolling
Updated:  12/31/1969
Circle Park Behavioral Health Services
mi
from
Florence, SC
Testing a Promising Treatment for Youth Substance Abuse in a Community Setting
Testing a Promising Treatment for Youth Substance Abuse in a Community Setting
Status: Enrolling
Updated: 12/31/1969
Circle Park Behavioral Health Services
mi
from
Florence, SC
Click here to add this to my saved trials
Skills to Enhance Positive Affect in Suicidal Adolescents
Skills to Enhance Positive Affect in Suicidal Adolescents
Status: Enrolling
Updated:  12/31/1969
Butler Hospital
mi
from
Providence, RI
Skills to Enhance Positive Affect in Suicidal Adolescents
Skills to Enhance Positive Affect in Suicidal Adolescents
Status: Enrolling
Updated: 12/31/1969
Butler Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
rTMS in First Episode Psychosis
Cortical Activation and Cognitive Performance During Repetitive Transcranial Magnetic Stimulation in First-Episode Psychosis: A Pilot Study
Status: Enrolling
Updated:  12/31/1969
IU Center for NeuroImaging
mi
from
Indianapolis, IN
rTMS in First Episode Psychosis
Cortical Activation and Cognitive Performance During Repetitive Transcranial Magnetic Stimulation in First-Episode Psychosis: A Pilot Study
Status: Enrolling
Updated: 12/31/1969
IU Center for NeuroImaging
mi
from
Indianapolis, IN
Click here to add this to my saved trials
rTMS in First Episode Psychosis
Cortical Activation and Cognitive Performance During Repetitive Transcranial Magnetic Stimulation in First-Episode Psychosis: A Pilot Study
Status: Enrolling
Updated:  12/31/1969
Prevention and Recovery Center for Early Psychosis
mi
from
Indianapolis, IN
rTMS in First Episode Psychosis
Cortical Activation and Cognitive Performance During Repetitive Transcranial Magnetic Stimulation in First-Episode Psychosis: A Pilot Study
Status: Enrolling
Updated: 12/31/1969
Prevention and Recovery Center for Early Psychosis
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Using Smartphones to Provide Recovery Support Services
Using Smartphones to Provide Recovery Support Services Experiment
Status: Enrolling
Updated:  12/31/1969
Haymarket
mi
from
Chicago, IL
Using Smartphones to Provide Recovery Support Services
Using Smartphones to Provide Recovery Support Services Experiment
Status: Enrolling
Updated: 12/31/1969
Haymarket
mi
from
Chicago, IL
Click here to add this to my saved trials
Using Smartphones to Provide Recovery Support Services
Using Smartphones to Provide Recovery Support Services Experiment
Status: Enrolling
Updated:  12/31/1969
Chestnut Health Systems
mi
from
Chicago, IL
Using Smartphones to Provide Recovery Support Services
Using Smartphones to Provide Recovery Support Services Experiment
Status: Enrolling
Updated: 12/31/1969
Chestnut Health Systems
mi
from
Chicago, IL
Click here to add this to my saved trials
Using Smartphones to Provide Recovery Support Services
Using Smartphones to Provide Recovery Support Services Experiment
Status: Enrolling
Updated:  12/31/1969
Chestnut Health Systems
mi
from
Normal, IL
Using Smartphones to Provide Recovery Support Services
Using Smartphones to Provide Recovery Support Services Experiment
Status: Enrolling
Updated: 12/31/1969
Chestnut Health Systems
mi
from
Normal, IL
Click here to add this to my saved trials
Contingency Management for Alcohol Use Disorders
Contingency Management for Alcohol Use Disorders
Status: Enrolling
Updated:  12/31/1969
The Hospital of Central Connecticut at New Britain General
mi
from
New Britain, CT
Contingency Management for Alcohol Use Disorders
Contingency Management for Alcohol Use Disorders
Status: Enrolling
Updated: 12/31/1969
The Hospital of Central Connecticut at New Britain General
mi
from
New Britain, CT
Click here to add this to my saved trials
Contingency Management for Alcohol Use Disorders
Contingency Management for Alcohol Use Disorders
Status: Enrolling
Updated:  12/31/1969
Farrell Treatment Center
mi
from
New Britain, CT
Contingency Management for Alcohol Use Disorders
Contingency Management for Alcohol Use Disorders
Status: Enrolling
Updated: 12/31/1969
Farrell Treatment Center
mi
from
New Britain, CT
Click here to add this to my saved trials
Contingency Management for Alcohol Use Disorders
Contingency Management for Alcohol Use Disorders
Status: Enrolling
Updated:  12/31/1969
Behavioral Health Network, Inc.
mi
from
Springfield, MA
Contingency Management for Alcohol Use Disorders
Contingency Management for Alcohol Use Disorders
Status: Enrolling
Updated: 12/31/1969
Behavioral Health Network, Inc.
mi
from
Springfield, MA
Click here to add this to my saved trials
The Tailgate Study: A Pilot Study Measuring the Impact of Acute Alcohol Intake on Intrahepatic Lipid
The Tailgate Study: A Pilot Study Measuring the Impact of Acute Alcohol Intake on Intrahepatic Lipid
Status: Enrolling
Updated:  12/31/1969
University of Missouri
mi
from
Columbia, MO
The Tailgate Study: A Pilot Study Measuring the Impact of Acute Alcohol Intake on Intrahepatic Lipid
The Tailgate Study: A Pilot Study Measuring the Impact of Acute Alcohol Intake on Intrahepatic Lipid
Status: Enrolling
Updated: 12/31/1969
University of Missouri
mi
from
Columbia, MO
Click here to add this to my saved trials
Improving Mental Health Outcomes: Building an Adaptive Implementation Strategy
Improving Mental Health Outcomes: Building an Adaptive Implementation
Status: Enrolling
Updated:  12/31/1969
Colorado Access
mi
from
Denver, CO
Improving Mental Health Outcomes: Building an Adaptive Implementation Strategy
Improving Mental Health Outcomes: Building an Adaptive Implementation
Status: Enrolling
Updated: 12/31/1969
Colorado Access
mi
from
Denver, CO
Click here to add this to my saved trials
Improving Mental Health Outcomes: Building an Adaptive Implementation Strategy
Improving Mental Health Outcomes: Building an Adaptive Implementation
Status: Enrolling
Updated:  12/31/1969
University of Michigan
mi
from
Ann Arbor, MI
Improving Mental Health Outcomes: Building an Adaptive Implementation Strategy
Improving Mental Health Outcomes: Building an Adaptive Implementation
Status: Enrolling
Updated: 12/31/1969
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Neuroimaging, Omega-3 and Reward in Adults With ADHD (NORAA) Trial
Neuroimaging Omega-3 and Reward in Adults With ADHD (NORAA) Trial
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Neuroimaging, Omega-3 and Reward in Adults With ADHD (NORAA) Trial
Neuroimaging Omega-3 and Reward in Adults With ADHD (NORAA) Trial
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Wisconsin Center for the Neuroscience and Psychophysiology of Meditation
Wisconsin Center for the Neuroscience and Psychophysiology of Meditation
Status: Enrolling
Updated:  12/31/1969
UW Madison, Center for Investigating Healthy Minds at the Waisman Center
mi
from
Madison, WI
Wisconsin Center for the Neuroscience and Psychophysiology of Meditation
Wisconsin Center for the Neuroscience and Psychophysiology of Meditation
Status: Enrolling
Updated: 12/31/1969
UW Madison, Center for Investigating Healthy Minds at the Waisman Center
mi
from
Madison, WI
Click here to add this to my saved trials
Wisconsin Center for the Neuroscience and Psychophysiology of Meditation
Wisconsin Center for the Neuroscience and Psychophysiology of Meditation
Status: Enrolling
Updated:  12/31/1969
UW-Madison, Asthma, Allergy and Pulmonary Research Center
mi
from
Madison, WI
Wisconsin Center for the Neuroscience and Psychophysiology of Meditation
Wisconsin Center for the Neuroscience and Psychophysiology of Meditation
Status: Enrolling
Updated: 12/31/1969
UW-Madison, Asthma, Allergy and Pulmonary Research Center
mi
from
Madison, WI
Click here to add this to my saved trials
Wisconsin Center for the Neuroscience and Psychophysiology of Meditation
Wisconsin Center for the Neuroscience and Psychophysiology of Meditation
Status: Enrolling
Updated:  12/31/1969
UW-Health Sports Medicine & Integrative Medicine Program
mi
from
Madison, WI
Wisconsin Center for the Neuroscience and Psychophysiology of Meditation
Wisconsin Center for the Neuroscience and Psychophysiology of Meditation
Status: Enrolling
Updated: 12/31/1969
UW-Health Sports Medicine & Integrative Medicine Program
mi
from
Madison, WI
Click here to add this to my saved trials
Wisconsin Center for the Neuroscience and Psychophysiology of Meditation
Wisconsin Center for the Neuroscience and Psychophysiology of Meditation
Status: Enrolling
Updated:  12/31/1969
Center for Sleep and Consciousness (and Wisconsin Sleep Clinic)
mi
from
Madison, WI
Wisconsin Center for the Neuroscience and Psychophysiology of Meditation
Wisconsin Center for the Neuroscience and Psychophysiology of Meditation
Status: Enrolling
Updated: 12/31/1969
Center for Sleep and Consciousness (and Wisconsin Sleep Clinic)
mi
from
Madison, WI
Click here to add this to my saved trials
Study Testing if Fast or Slow rTMS is Better for the Treatment of Posttraumatic Stress Disorder (PTSD)
Randomized Trial of 1 Hz Versus 10 Hz Right Prefrontal Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Posttraumatic Stress Disorder (PTSD)
Status: Enrolling
Updated:  12/31/1969
James A. Haley VAH
mi
from
Tampa, FL
Study Testing if Fast or Slow rTMS is Better for the Treatment of Posttraumatic Stress Disorder (PTSD)
Randomized Trial of 1 Hz Versus 10 Hz Right Prefrontal Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Posttraumatic Stress Disorder (PTSD)
Status: Enrolling
Updated: 12/31/1969
James A. Haley VAH
mi
from
Tampa, FL
Click here to add this to my saved trials
Pharmacokinetic and Pharmacodynamic Effects of Oral Cannabis
Pharmacokinetic and Pharmacodynamic Effects of Oral Cannabis
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins School of Medicine Behavioral Pharmacology Research Unit
mi
from
Baltimore, MD
Pharmacokinetic and Pharmacodynamic Effects of Oral Cannabis
Pharmacokinetic and Pharmacodynamic Effects of Oral Cannabis
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins School of Medicine Behavioral Pharmacology Research Unit
mi
from
Baltimore, MD
Click here to add this to my saved trials
Autologous Umbilical Cord Blood Infusion for Children With Autism Spectrum Disorder (ASD)
Autologous Umbilical Cord Blood Infusion for Children With Autism Spectrum Disorder (ASD)
Status: Enrolling
Updated:  12/31/1969
Duke Univ Med Ctr
mi
from
Durham, NC
Autologous Umbilical Cord Blood Infusion for Children With Autism Spectrum Disorder (ASD)
Autologous Umbilical Cord Blood Infusion for Children With Autism Spectrum Disorder (ASD)
Status: Enrolling
Updated: 12/31/1969
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Chronotherapy Randomized Controlled Trial
Adjunct Total Sleep Deprivation, Sleep Phase Advance, and White Light Therapy Vs. Partial Sleep Deprivation, Sleep Phase Delay, and Amber Light Therapy as Adjunctive Treatments in Acutely Suicidal and Depressed Inpatients.
Status: Enrolling
Updated:  12/31/1969
Medical University of South Carolina
mi
from
Charleston, SC
Chronotherapy Randomized Controlled Trial
Adjunct Total Sleep Deprivation, Sleep Phase Advance, and White Light Therapy Vs. Partial Sleep Deprivation, Sleep Phase Delay, and Amber Light Therapy as Adjunctive Treatments in Acutely Suicidal and Depressed Inpatients.
Status: Enrolling
Updated: 12/31/1969
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Effects of Cannabis Administration Routes on Human Performance and Pharmacokinetics
Effects of Cannabis Administration Routes on Human Performance and Pharmacokinetics
Status: Enrolling
Updated:  12/31/1969
National Institute on Drug Abuse
mi
from
Baltimore, MD
Effects of Cannabis Administration Routes on Human Performance and Pharmacokinetics
Effects of Cannabis Administration Routes on Human Performance and Pharmacokinetics
Status: Enrolling
Updated: 12/31/1969
National Institute on Drug Abuse
mi
from
Baltimore, MD
Click here to add this to my saved trials
Predictive MRI Metrics for Tumor Aggressiveness in Papillary Thyroid Cancer
Predictive MRI Metrics for Tumor Aggressiveness in Papillary Thyroid Cancer
Status: Enrolling
Updated:  12/31/1969
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Predictive MRI Metrics for Tumor Aggressiveness in Papillary Thyroid Cancer
Predictive MRI Metrics for Tumor Aggressiveness in Papillary Thyroid Cancer
Status: Enrolling
Updated: 12/31/1969
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Sleep Disturbance and Relapse in Individuals With Alcohol Dependence: An Exploratory Mixed Methods Study
Sleep Disturbance and Relapse in Individuals With Alcohol Dependence: An Exploratory Mixed Methods Study
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Sleep Disturbance and Relapse in Individuals With Alcohol Dependence: An Exploratory Mixed Methods Study
Sleep Disturbance and Relapse in Individuals With Alcohol Dependence: An Exploratory Mixed Methods Study
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Self-Management Training and Automated Telehealth to Improve SMI Health Outcomes
Self-Management Training and Automated Telehealth to Improve SMI Health Outcomes
Status: Enrolling
Updated:  12/31/1969
Vinfen
mi
from
Cambridge, MA
Self-Management Training and Automated Telehealth to Improve SMI Health Outcomes
Self-Management Training and Automated Telehealth to Improve SMI Health Outcomes
Status: Enrolling
Updated: 12/31/1969
Vinfen
mi
from
Cambridge, MA
Click here to add this to my saved trials
Self-Management Training and Automated Telehealth to Improve SMI Health Outcomes
Self-Management Training and Automated Telehealth to Improve SMI Health Outcomes
Status: Enrolling
Updated:  12/31/1969
Bay Cove Human Services
mi
from
Boston, MA
Self-Management Training and Automated Telehealth to Improve SMI Health Outcomes
Self-Management Training and Automated Telehealth to Improve SMI Health Outcomes
Status: Enrolling
Updated: 12/31/1969
Bay Cove Human Services
mi
from
Boston, MA
Click here to add this to my saved trials
A Pharmacokinetic/Pharmacodynamic Genetic Variation Treatment Algorithm Versus Treatment As Usual for Management Of Depression
A Pharmacokinetic/Pharmacodynamic Genetic Variation Treatment Algorithm Versus Treatment As Usual for Management of Depression
Status: Enrolling
Updated:  12/31/1969
The Mayo Clinic
mi
from
Rochester, MN
A Pharmacokinetic/Pharmacodynamic Genetic Variation Treatment Algorithm Versus Treatment As Usual for Management Of Depression
A Pharmacokinetic/Pharmacodynamic Genetic Variation Treatment Algorithm Versus Treatment As Usual for Management of Depression
Status: Enrolling
Updated: 12/31/1969
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Treatment of Pediatric Anxiety Disorders by Predicting Treatment Response Through Biocellular Markers and Sleep
Treatment of Pediatric Anxiety Disorders by Predicting Treatment Response Through Biocellular Markers and Sleep
Status: Enrolling
Updated:  12/31/1969
NYSPI
mi
from
New York, NY
Treatment of Pediatric Anxiety Disorders by Predicting Treatment Response Through Biocellular Markers and Sleep
Treatment of Pediatric Anxiety Disorders by Predicting Treatment Response Through Biocellular Markers and Sleep
Status: Enrolling
Updated: 12/31/1969
NYSPI
mi
from
New York, NY
Click here to add this to my saved trials
A Trial To Assess Risk of Delirium in Older Adults Undergoing Hip Fracture Surgery With Spinal or General Anesthesia
A Randomized Controlled Trial To Assess Risk of Delirium in Older Adults Undergoing Hip Fracture Surgery With Spinal or General Anesthesia
Status: Enrolling
Updated:  12/31/1969
Hosptial of the University of Pennsylvania
mi
from
Philadelphia, PA
A Trial To Assess Risk of Delirium in Older Adults Undergoing Hip Fracture Surgery With Spinal or General Anesthesia
A Randomized Controlled Trial To Assess Risk of Delirium in Older Adults Undergoing Hip Fracture Surgery With Spinal or General Anesthesia
Status: Enrolling
Updated: 12/31/1969
Hosptial of the University of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials